Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia

Source : https://www.nice.org.uk/guidance/ta733/documents/html-content-2

The Appraisal Committee has prepared a Final Appraisal Document (FAD) on Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia and submitted it to NICE. The FAD has been sent to...

Association of circulating oxidized LDL-C/LDL-C ratio with severity of coronary atherosclerosis and other emerging biomarkers of cardiovascular disease in patients with type 2 diabetes

Source : https://europepmc.org/article/ppr/ppr406901

Background: Atherosclerosis cardiovascular diseases (ASCVD) are the leading cause of mortality and morbidity in patients with diabetes. But there are still no simpler and more effective biomarkers which can predict...

New players in the treatment of hypercholesterolaemia: focus on bempedoic acid and inclisiran - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34650356/

Dyslipidaemias and in particular elevated plasma low-density lipoprotein cholesterol (LDL-C) levels are major risk factors for atherosclerotic cardiovascular disease (ASCVD). Indeed, the more LDL-C is reduced the larger will be...

Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors The Multi-Ethnic Study of Atherosclerosis

Source : https://jamanetwork.com/journals/jamacardiology/article-abstract/2781973

Lipid biomarkers and Cancer risk - a population-based prospective cohort study in Taiwan - Lipids in Health and Disease

Source : https://lipidworld.biomedcentral.com/articles/10.1186/s12944-021-01570-1

Background Blood lipids are essential components for cellular growth. An inverse association between serum lipid levels and risk of cancer has led to a controversy among previous studies. The aim...